Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Cydy pulling out of Hiv MDR

<< Previous

Bullboard Posts

Next >>

Comment by qwerty22on Oct 29, 2022 5:04pm

120 Views

Post# 35057994

RE:RE:Cydy pulling out of Hiv MDR

This happened after close on Friday. Let's see what happens Monday but I have to say I was reading some CYDY bull-boards and the derangement is real. Some think this is positive!

The fun thing is they say they can't go forward for VARIOUS REASONS then go on to blame it all on CRO data handling. I wish there was more obligation to reveal all the reasons, I bet they are an interesting read.

SPCEO1 wrote: And yet, CYDY still has a market cap nearly 2x that of THTX! This will not always be the case but it has been for far longer than I would have ever imagined possible. There is no logical justification for this but CYDY pursued retail investors and THTX did not and that likely is a big part of how this has happened and persisted for so long. It has clearly been hard to deal with THTX's chronic underperformance, even while the company has gotten better in most tangible ways, but it is even harder whenever I take a glimpse at CYDY's market cap. It is just galling.

But if something can't continue, it usually doesn't. THTX's time is likely coming and my understanding is they are making a more serious push on the retail side of the equation. Let's hope they get the results CYDY has gotten from those efforts.

palinc2000 wrote: CytoDyn Announces Voluntary Withdrawal of BLA for HIV-MDR Due to CRO Data Management Issues
https://seekingalpha.com/pr/18996550-cytodyn-announces-voluntary-withdrawal-of-bla-for-hiv-mdr-due-to-cro-data-management-issues